The advertisement promotes GOMEKLI (mirdametib), highlighting its classification as a systemic therapy for NF1-PN and providing important safety information regarding ocular toxicity.
Creative Information
| CID: | 45cfd886-35bf-4ac4-a04f-f55946d424e1 |
| CRID: | 82_7427-923897 |
| Domain: | ajmc.com |
| Seat: | PP |
| Size: | 300x600 |
| Bid: | $2.83 |
| Timestamp: | 11/4/2025, 4:53:36 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/4/2025, 6:57:32 PM | 6.78s | |
| adomain_analysis | success | 11/4/2025, 7:49:03 PM | 4.33s | |
| adomain_capture | success | 11/4/2025, 7:47:22 PM | 0.09s | |
| ad_render | success | 11/4/2025, 6:57:25 PM | 23.35s | |
| brand_mapping | success | 11/4/2025, 4:53:37 PM | 0.12s | |
Analysis Results
Ad Format: banner
Brands: AJMC
Sensitive:Misleading Health ClaimsUnverified Medical TreatmentsPharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 331.84 KB | ||||||||||||||||||||||
| Render Time: | 7.86 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 337.40 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


